Chapter 63
Char Syndrome and TFAP2B Mutations
Bruce D. Gelb,
Bruce D. Gelb
Search for more papers by this authorBruce D. Gelb,
Bruce D. Gelb
Search for more papers by this authorBook Editor(s):Michael Artman MD, D. Woodrow Benson MD, PhD,
Deepak Srivastava MD,
Makoto Nakazawa MD,
D. Woodrow Benson MD, PhD
Professor of Pediatrics, Director, Cardiovascular Genetics, Division of Cardiology, Cincinnati Children's Hospital Medical Center
Search for more papers by this authorDeepak Srivastava MD
Pogue Distinguished Chair in Research on Cardiac Birth Defects, Joel B. Steinberg, M.D. Chair in Pediatrics Professor, Departments of Pediatrics and Molecular Biology, University of Texas, Southwestern Medical Center at Dallas
Search for more papers by this authorMakoto Nakazawa MD
Professor and Head, Pediatric Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University
Search for more papers by this authorFirst published: 01 January 2005
Summary
This chapter contains sections titled:
-
Clinical description of Char syndrome
-
Genetic mapping and disease gene discovery
-
Tfap2b and its protein product
-
Molecular pathology of Char syndrome
-
Genotype/phenotype correlation
References
- Char F. Peculiar facies with short philtrum, duck-bill lips, ptosis and low-set ears - a new syndrome? Birth Defects Orig Artic Ser 1978; 14: 303–5.
- Temple IK. Char syndrome (unusual mouth, patent ductus arteriosus, phalangeal anomalies). Clin Dysmorphol 1992; 1: 17–21.
- Davidson HR. A large family with patent ductus arteriosus and unusual face. J Med Genet 1993; 30: 503–5.
- Sletten LJ, Pierpont ME. Familial occurrence of patent ductus arteriosus. Am J Med Genet 1995; 57: 27–30.
-
Slavotinek A,
Clayton-Smith J,
Super M.
Familial patent ductus arteriosus: a further case of CHAR syndrome.
Am J Med Genet
1997;
71: 229–32.
10.1002/(SICI)1096-8628(19970808)71:2<229::AID-AJMG22>3.0.CO;2-F PubMed Web of Science® Google Scholar
- Sweeney E, Fryer A, Walters M. Char syndrome: a new family and review of the literature emphasising the presence of symphalangism and the variable phenotype. Clin Dysmorphol 2000; 9: 177–82.
- Bertola DR, Kim CA, Sugayama SM, et al. Further delineation of Char syndrome. Pediatr Int 2000; 42: 85–8.
- Zannolli R, Mostardini R, Matera M, et al. Char syndrome: an additional family with polythelia, a new finding. Am J Med Genet 2000; 95: 201–3.
- Satoda M, Pierpont ME, Diaz GA, Bornemeier RA, Gelb BD. Char syndrome, an inherited disorder with patent ductus arteriosus, maps to chromosome 6p12-p21. Circulation 1999; 99: 3036–42.
- Satoda M, Zhao F, Diaz GA, et al. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet 2000; 25: 42–46.
- Zhao F, Weismann CG, Satoda M, et al. Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. Am J Hum Genet 2001; 69: 695–703.
- Moser M, Imhof A, Pscherer A, et al. Cloning and characterization of a second AP-2 transcription factor:AP-2 beta. Development 1995; 121: 2779–88.
- Williamson JA, Bosher JM, Skinner A, et al. Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. Genomics 1996; 35: 262–4.
- Wankhade S, Yu Y, Weinberg J, Tainsky MA, Kannan P. Characterization of the activation domains of AP-2 family transcription factors. J Biol Chem 2000; 275: 29701–8.
-
Moser M,
Ruschoff J,
Buettner R.
Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis.
Dev Dyn
1997;
208: 115–24.
10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5 CAS PubMed Web of Science® Google Scholar
- Moser M, Pscherer A, Roth C, et al. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. Genes Dev 1997; 11: 1938–48.
- Monge I, Mitchell PJ. DAP-2, the Drosophila homolog of transcription factor AP-2. Mech Dev 1998; 76: 191–5.
- Bauer R, McGuffin ME, Mattox W, Tainsky MA. Cloning and characterization of the Drosophila homologue of the AP-2 transcription factor. Oncogene 1998; 17: 1911–22.
- Kerber B, Monge I, Mueller M, Mitchell PJ, Cohen SM. The AP-2 transcription factor is required for joint formation and cell survival in Drosophila leg development. Development 2001; 128: 1231–8.
- Monge I, Krishnamurthy R, Sims D, Hirth F, et al. Drosophila transcription factor AP-2 in proboscis, leg and brain central complex development. Development 2001; 128: 1239–52.
- Basson CT, Huang T, Lin RC, et al. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci USA 1999; 96: 2919–24.
- International Agency forResearch on-Cancer. IACR PT53 Mutation Database: 2001.
- Holliday R, Grigg GW. DNA methylation and mutation. Mutat Res 1993; 285: 61–7.
- Pabo CO, Sauer RT. Transcription factors: structural families and principles of DNA recognition. Annu Rev Biochem 1992; 61: 1053–95.
- Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional coactivator. Embo J 1999; 18: 2551–62.
